5-HT2C receptor modulation and the treatment of obesity.
Cerebrus plc, Oakdene Court, 613 Reading Road, Winnersh, Wokingham RG41 5UA, UK.
M J
MJ
Bickerdike
S P
SP
Vickers
C T
CT
Dourish
D000818:Animals; D001067:Appetite Depressants / Q000494:pharmacology / Q000627:therapeutic use*; D003503:Cyclobutanes / Q000627:therapeutic use; D004195:Disease Models, Animal; D005277:Fenfluramine / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009765:Obesity / Q000188:drug therapy*; D044405:Receptor, Serotonin, 5-HT2C; D011985:Receptors, Serotonin / Q000187:drug effects / Q000502:physiology*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D001067:Appetite Depressants; D003503:Cyclobutanes; D005277:Fenfluramine; D044405:Receptor, Serotonin, 5-HT2C; D011985:Receptors, Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; C058254:sibutramine